Literature DB >> 15328085

In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.

Aya Yekutiel1, Itamar Shalit, Yona Shadkchan, Nir Osherov.   

Abstract

Caspofungin (CAS) inhibits fungal cell wall synthesis. Sulfamethoxazole (SMX) inhibits folate biosynthesis and is active in vitro against Aspergillus spp. We studied the activities of the combination of CAS and SMX against 31 Aspergillus isolates and compared them with that of SMX combined with amphotericin B (AMB) or itraconazole (ITC). MICs and minimal effective concentrations (MECs) were determined by the NCCLS broth microdilution method. With MIC endpoints, the combination of SMX and CAS showed synergy or synergy to additivity against 29 of 31 isolates. With MEC endpoints, synergy to additivity was found against 12 of 31 isolates and indifference was displayed against the rest of them. SMX in combination with AMB or ITC was not truly synergistic, while synergy to additivity was found for SMX-AMB and SMX-ITC against 17 of 31 and 3 of 12 isolates, respectively. No antagonism was found with any of the drug combinations. Further analysis of the synergy of CAS and SMX was performed by detailed measurement of hyphal length by microscopy and time-dependent 2,3-bis(2-methoxy-4-nitro-5-[(sulfenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT)-based hyphal damage experiments. With MEC endpoints, the combination of CAS and SMX was characterized by a greater than 50% decrease in hyphal length compared to the hyphal lengths achieved with double the concentration of each drug alone. The XTT-based hyphal damage studies showed a statistically significant (P < 0.05) reduction in viability with CAS and SMX in combination compared to the viabilities achieved with double the concentration of each drug alone. These findings support the synergy results found by using MIC endpoints and suggest that visual MEC measurements may not be sufficient to identify the synergistic interactions seen by more sensitive, quantitative methods. Animal models are required to validate the significance of the synergy of CAS and SMX against Aspergillus spp. observed in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328085      PMCID: PMC514744          DOI: 10.1128/AAC.48.9.3279-3283.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Folic acid antagonism of sulfa drug treatments.

Authors:  Ann M Bayly; Ian G Macreadie
Journal:  Trends Parasitol       Date:  2002-02

2.  Prevention of invasive aspergillosis in AIDS by sulfamethoxazole.

Authors:  J Afeltra; J F Meis; J W Mouton; P E Verweij
Journal:  AIDS       Date:  2001-05-25       Impact factor: 4.177

3.  In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species.

Authors:  Javier Afeltra; Jacques F G M Meis; Roxana G Vitale; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Signature-tagged and directed mutagenesis identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity.

Authors:  J S Brown; A Aufauvre-Brown; J Brown; J M Jennings; H Arst; D W Holden
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

5.  In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

Authors:  Sevtap Arikan; Mario Lozano-Chiu; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 6.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

7.  Colorimetric assay for antifungal susceptibility testing of Aspergillus species.

Authors:  J Meletiadis; J W Mouton; J F Meis; B A Bouman; J P Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.

Authors:  C C Chiou; N Mavrogiorgos; E Tillem; R Hector; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 9.  Invasive Aspergillus infections in hematologic malignancy patients.

Authors:  Sofia Perea; Thomas F Patterson
Journal:  Semin Respir Infect       Date:  2002-06

10.  In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

Authors:  Sofia Perea; Gloria Gonzalez; Annette W Fothergill; William R Kirkpatrick; Michael G Rinaldi; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more
  5 in total

1.  In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum.

Authors:  Raimunda Sâmia Nogueira Brilhante; Maria Auxiliadora Bezerra Fechine; Rossana de Aguiar Cordeiro; Marcos Fábio Gadelha Rocha; Joyce Fonteles Ribeiro; André Jalles Monteiro; Rita Amanda Chaves de Lima; Jacó Ricarte Lima Mesquita; Zoilo Pires de Camargo; José Júlio Costa Sidrim
Journal:  Antimicrob Agents Chemother       Date:  2010-06-21       Impact factor: 5.191

2.  Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.

Authors:  Charalampos Antachopoulos; Joseph Meletiadis; Tin Sein; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

3.  Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs.

Authors:  Hassan E Eldesouky; Abdelrahman Mayhoub; Tony R Hazbun; Mohamed N Seleem
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

4.  Comparison of echinocandin antifungals.

Authors:  Gregory Eschenauer; Daryl D Depestel; Peggy L Carver
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

5.  Riboflavin and pantothenic acid biosynthesis are crucial for iron homeostasis and virulence in the pathogenic mold Aspergillus fumigatus.

Authors:  Anna-Maria Dietl; Zohar Meir; Yona Shadkchan; Nir Osherov; Hubertus Haas
Journal:  Virulence       Date:  2018       Impact factor: 5.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.